Guanze Medical Information Industry (Holding) Co., Ltd. (HKG:2427)

HKG:2427 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	18.37	21.93	28.23	68.35	29.37	20.24
Short-Term Investments	-	-	-	0.09	0.06	0.02
Cash & Short-Term Investments	18.37	21.93	28.23	68.44	29.42	20.25
Cash Growth	-45.92%	-22.30%	-58.76%	132.59%	45.27%	237.51%
Accounts Receivable	106.1	163.29	174.19	120.18	154.95	137.25
Other Receivables	-	0.29	13.83	5.78	82.42	-
Receivables	106.1	163.58	188.02	125.95	237.37	137.25
Inventory	12.38	7.37	14.37	10.89	15.41	12.57
Other Current Assets	53.42	20.37	14.87	66.91	10.88	3.41
Total Current Assets	190.26	213.25	245.48	272.19	293.08	173.49
Property, Plant & Equipment	46.61	49.22	53.03	38.98	34.36	29.49
Other Intangible Assets	1.74	2.39	3.67	0.14	0.17	0.2
Long-Term Deferred Tax Assets	1.98	1.98	1.98	1.18	0.11	0.07
Long-Term Deferred Charges	-	-	-	-	-	0.81
Other Long-Term Assets	0.33	3.85	-	-	-	-
Total Assets	240.94	270.69	304.17	312.49	327.72	204.05

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.7	1.24	0.56	1.38	2.29	14.81
Accrued Expenses	-	10.72	9.05	1.16	0.71	0.32
Short-Term Debt	16.38	12.76	17.71	21.15	26.91	19.58
Current Portion of Leases	0.15	0.18	0.28	0.31	0.05	0.07
Current Income Taxes Payable	8.74	10.32	12.41	10.83	6.93	2.97
Current Unearned Revenue	0.46	0.47	0.94	1.03	1.59	1.26
Other Current Liabilities	12.4	2.35	2.56	5.93	28.51	2.32
Total Current Liabilities	39.82	38.05	43.51	41.78	66.99	41.34
Long-Term Leases	0.29	0.37	0.16	0.39	0.1	0.15
Total Liabilities	40.11	38.41	43.66	42.18	67.08	41.49

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	8.58	8.58	8.58	8.58	8.58	-
Additional Paid-In Capital	-	78.07	78.07	78.07	78.07	-
Retained Earnings	-	105.42	135.13	136.12	126.86	108.92
Comprehensive Income & Other	191.66	39.3	37.57	46.63	46.63	53.48
Total Common Equity	200.24	231.36	259.34	269.4	260.14	162.4
Minority Interest	0.59	0.92	1.16	0.92	0.51	0.16
Shareholders' Equity	200.83	232.28	260.51	270.32	260.64	162.56
Total Liabilities & Equity	240.94	270.69	304.17	312.49	327.72	204.05

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	16.81	13.32	18.15	21.85	27.06	19.8
Net Cash (Debt)	1.56	8.62	10.08	46.59	2.37	0.45
Net Cash Growth	-91.69%	-14.51%	-78.36%	1868.36%	423.67%	-
Net Cash Per Share	0.00	0.01	0.01	0.05	0.00	0.00
Filing Date Shares Outstanding	950	950	950	950	950	-
Total Common Shares Outstanding	950	950	950	950	950	-
Working Capital	150.45	175.21	201.98	230.41	226.09	132.15
Book Value Per Share	0.21	0.24	0.27	0.28	0.27	-
Tangible Book Value	198.49	228.97	255.67	269.26	259.97	162.2
Tangible Book Value Per Share	0.21	0.24	0.27	0.28	0.27	-
Buildings	-	7.18	7.18	7.18	7.18	6.79
Machinery	-	75.66	72.7	51.67	34.6	25.66
Leasehold Improvements	-	0.52	0.23	0.23	0.23	0.23

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 10, 2026

Data Sources Report a data error